HPLC method with monolithic column for simultaneous determination of irbesartan and hydrochlorothiazide in tablets

1. S. Miura, S. S. Karnik and K. Saku, Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects, J. Renin-Angiotensin-Aldosterone Sys. 12 (2011) 1-7; DOI: 10.1177/ 1470320310370852.Search in Google Scholar

2. M. Burnier and H. R. Brunner, Angiotensin II receptor antagonists, Lancet 355 (2000) 637-645; DOI: 10.1016/S0140-6736(99)10365-9.10.1016/S0140-6736(99)10365-9Search in Google Scholar

3. A. Lant, Diuretic drugs progress in clinical pharmacology, Drugs 31 (1986) 40-55; DOI: 10.2165/ 00003495-198600314-00006.10.2165/00003495-198600314-00006Search in Google Scholar

4. J. M. Neutel, E. Saunders, G. L. Bakris, W. C. Cushman, K. C. Ferdinand, E. O. Ofili, J. R. Sowers and M. A. Weber, The efficacy and safety of low- and high dose fixed combinations of irbesartan/ hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: The inclusive trial, J. Clin. Hyperten. 7 (2005) 578-586; DOI: 10.1111/j.1524-6175.2004.04720.x.10.1111/j.1524-6175.2004.04720.xSearch in Google Scholar

5. M. R. Weir, J. M. Neutel, A. Bhaumik, M. E. D. Obaldia and P. Lapuerta, The efficacy and safety of initial use of irbesartan/hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular risk, J. Clin. Hyperten. 9 (2007) 23-30; DOI: 10.1111/ j.1524-6175.2007.07805.x.10.1111/j.1524-6175.2007.07805.xSearch in Google Scholar

6. H. E. Abdellatef, Extractive-spectrophotometric determination of disopyramide and irbesartan in their pharmaceutical formulation, Spectrochim. Acta A 66 (2007) 1248-1254; DOI: 10.1016/j. saa.2006.06.015.Search in Google Scholar

7. S. R. El-Shaboury, S. A. Hussein, N. A. Mohamed and M. M. El-Sutohy, Spectrofluorimetric method for determination of some angiotensin II receptor antagonists, J. Pharm. Biomed. Anal. 2 (2012) 12-18; DOI: 10.1016/j.jpha.2011.10.005.10.1016/j.jpha.2011.10.005Search in Google Scholar

8. B. Bozal, B. Doghan-Topal, B. Uslu, S. A. Özkan and H. Y. Aboul-Enein, Quantitative analysis of irbesartan in pharmaceuticals and human biological fluids by voltammetry, Anal. Lett. 42 (2009) 2322-2338; DOI: 10.1080/00032710903137491.10.1080/00032710903137491Search in Google Scholar

9. I. H. I. Habib, S. A. Weshahy, S. Toubar and M. M. A. El-Alamin, Adsorptive stripping voltammetric determination of irbesartan in bulk and pharmaceutical products, Pharm. Chem. J. 42 (2008) 438-442; DOI: 10.1007/s11094-008-0144-4.10.1007/s11094-008-0144-4Search in Google Scholar

10. S.-Y. Chang, D. B. Whigan, N. N. Vachharajani and R. Patel, High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine, J. Chromatogr. B 702 (1997) 149-155; DOI: 10.1016/S0378-4347(97)00387-3.10.1016/S0378-4347(97)00387-3Search in Google Scholar

11. E. Martín, O. Hernández, F. Jiménez and J. J. Arias, Simultaneous spectrophotometric determination of hydrochlorothiazide and pharmaceutical preparations, Anal. Lett. 28 (1995) 1449-1464; DOI: 10.1080/00032719508006406.10.1080/00032719508006406Search in Google Scholar

12. M. Omar, Spectrophotometric and spectrofluorimetric determination of certain diuretics through ternary complex formation with eosin and lead (II), J. Fluoresc. 20 (2010) 275-281; DOI: 10.1007/ s10895-009-0551-2.10.1007/s10895-009-0551-219823922Search in Google Scholar

13. B. Rezaei and S. Damiri, Multiwalled carbon nanotubes modified electrode as a sensor for adsorptive stripping voltammetric determination of hydrochlorothiazide, Sensors J. IEEE 8 (2008) 1523-1529; DOI: 10.1109/jsen.2008.923585.10.1109/JSEN.2008.923585Search in Google Scholar

14. G. Carlucci, G. Palumbo, P. Mazzeo and M. Giovanna Quaglia, Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatography, J. Pharm. Biomed. Anal. 23 (2000) 185-189; DOI: 10.1016/S0731-7085(00)00268-5.10.1016/S0731-7085(00)00268-5Search in Google Scholar

15. M. Kartal and N. Erk, Simultaneous determination of hydrochlorothiazide and amiloride hydrochloride by ratio spectra derivative spectrophotometry and high-performance liquid chromatography, J. Pharm. Biomed. Anal. 19 (1999) 477-485; DOI: 10.1016/S0731-7085(98)00241-6.10.1016/S0731-7085(98)00241-6Search in Google Scholar

16. S. Hillaert, K. De Grauwe and W. Van den Bossche, Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis, J. Chromatogr. A 924 (2001) 439-449; DOI: 10.1016/S0021-9673(01)00714-2.10.1016/S0021-9673(01)00714-2Search in Google Scholar

17. J. Joseph-Charles, S. Brault, C. Boyer, M. H. Langlois, L. Cabrero and J. P. Dubost, Simultaneous determination of irbesartan and hydrochlorothiazide in tablets by derivative spectrophotometry, Anal. Lett. 36 (2003) 2485-2495; DOI: 10.1081/al-120024337.10.1081/AL-120024337Search in Google Scholar

18. C. Vetuschi, A. Giannandrea, G. Carlucci and P. Mazzeo, Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry, Farmaco 60 (2005) 665-670; DOI: 10.1016/j.farmac.2005.04.013.10.1016/j.farmac.2005.04.013Search in Google Scholar

19. A. S. Khodke, L. V. Potale, M. C. Damle and K. G. Bothara, A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide, Pharm. Methods 1 (2010) 39-43; DOI: 10.4103/2229-4708.72229.10.4103/2229-4708.72229Search in Google Scholar

20. F. Coudoré, L. Harvard, S. Lefeuvre, E. M. Billaud, P. Beaune, G. Bobrie, M. Azizi, P. Prognon and S. Laurent, HPLC-DAD Analysis of hydrochlorothiazide and irbesartan in hypertensive patients on fixed-dose combination therapy, Chromatographia 74 (2011) 559-565; DOI: 10.1007/ s10337-011-2111-6.10.1007/s10337-011-2111-6Search in Google Scholar

21. N. Sultana, M. S. Arayne, S. S. Ali and S. Sajid, Simultaneous determination of olmesartan medoxomil and irbesartan and hydrochlorothiazide in pharmaceutical formulations and human serum using high performance liquid chromatography, Chin. J. Chromatogr. 26 (2008) 544-549; DOI: 10.1016/S1872-2059(08)60029-2.10.1016/S1872-2059(08)60029-2Search in Google Scholar

22. N. Erk, Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography, J. Chromatogr. B 784 (2003) 195-201; DOI: 10.1016/S1570-0232(02) 00759-6.Search in Google Scholar

23. L. F. Tutunji, M. F. Tutunji, M. I. Alzoubi, M. H. Khabbas and A. I. Arida, Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies, J. Pharm. Biomed. Anal. 51 (2010) 985-990; DOI: 10.1016/j.jpba.2009.10.023.10.1016/j.jpba.2009.10.02320004542Search in Google Scholar

24. Z. Vuji}, N. Mulavdi}, M. Smaji}, J. Brbori} and P. Stankovi}, Simultaneous analysis of irbesartan and hydrochlorothiazide: An improved HPLC method with the aid of a chemometric protocol, Molecules 17 (2012) 3461-3474; DOI: 10.3390/molecules17033461.10.3390/molecules17033461626817722426527Search in Google Scholar

25. F. Gerber, M. Krummen, H. Potgeter, A. Roth, C. Siffrin and C. Spoendlin, Practical aspects of fast reversed-phase high-performance liquid chromatography using 3 μm particle packed columns and monolithic columns in pharmaceutical development and production working under current good manufacturing practice, J. Chromatogr. A 1036 (2004) 127-133; DOI: 10.1016/j.chroma. 2004.02.056.Search in Google Scholar

26. R. Plumb, G. Dear, D. Mallett and J. Ayrton, Direct analysis of pharmaceutical compounds in human plasma with chromatographic resolution using an alkyl-bonded silica rod column, Rapid Commun. Mass Spectrom. 15 (2001) 986-993; DOI: 10.1002/rcm.329.10.1002/rcm.32911400208Search in Google Scholar

27. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), Current Step 4 version, Geneve November 2005; http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/ Step4/Q2_R1__Guideline.pdf; January 9, 2014.Search in Google Scholar

28. Department of Health and Human Services, Food and Drug Administration, Maryland, USA, Analytical Procedures and Methods Validation, Chemistry, Manufacturing, and Controls Documentation., US FDA, Silver Spring (MD), August 2000; http://www.fda.gov/downloads/Drugs/ Guidances/ucm122858.pdf; January 9, 2014.Search in Google Scholar

29. V. P. Rane, K. R. Patil, J. N. Sangshetti, R. D. Yeole and D. B. Shinde, Stability indicating LC method for simultaneous determination of irbesartan and hydrochlorothiazide in pharmaceutical preparations, J. Chromatogr Sci. 48 (2010) 595-600; DOI: 10.1093/chromsci/48.7.595. 10.1093/chromsci/48.7.59520819286Search in Google Scholar